Risk factors and outcomes associated with persistent vancomycin resistant enterococcal bacteremia

HIGHLIGHTS

• who: Emily Fox from the We conducted a single center, retrospective, case-control studyAdult patients (u2265 , years old) admitted to Stanford Hospital (Stanford, California, USA) between , and , with u2265 , blood culture positive for vancomycin resistant Enterococcus spp. were screened for inclusion. Case patients included those who had an episode of persistent bacteremia, defined as bacteremia for u2265 , days despite VRE-directed therapy. Control patients had nonpersistent bacteremia, defined as documented clearance of blood cultures within , days of active treatment initiation. Patients were excluded if they had incomplete data records, did not have repeat blood cultures drawn after . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.